A Study of Docetaxel and Lobaplatin vs. Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
Latest Information Update: 26 May 2024
At a glance
- Drugs Docetaxel (Primary) ; Lobaplatin (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Adverse reactions
- 16 May 2013 New trial record